https://dhfr-signal.com/index.....php/spatial-niche-ca
Particularly, dental management of ATRA is the very first choice treatment in Acute Promyelocytic Leukemia (APL) in grownups and NeuroBlastoma (N in children. Unfortunately, the encouraging results obtained for these diseases have not been converted yet to the centers for solid tumors. This might be due primarily to ATRA-resistance developed by cancer tumors cells and to inadequate delivery and targeting. This up-to-date analysis relates to present studies
Like
Comment
Share
